Patent Assignment
Reel/Frame 009781/0793
Merger
Recorded: 1999-03-02
Pages: 5
Assignor
SANDOZ LTD.
Executed: 1997-01-06
Assignee
NOVARTIS AG
SCHWARZWALDALLEE 215, BASEL, 4058, SWITZERLAND
Covered Properties
(15)
Organic Compounds
Patent:
4,438,103 →
Application:
05/856,617 →
Trans-N-Cinnamyl-N-Methyl- (1-Naphthylmethyl) Amine
Patent:
4,282,251 →
Application:
06/100,024 →
Benzoxadiazoles and Benzothiadiazoles, Their Preparation and Pharmaceutical Compositions Containing Them
Patent:
4,466,972 →
Application:
06/359,751 →
Novel Cyclosporins
Patent:
4,764,503 →
Application:
07/049,746 →
Treatment of Gastrointestinal Disorders
Patent:
4,910,193 →
Application:
07/090,986 →
Method of Combatting Pruning Wound Diseases
Patent:
4,897,427 →
Application:
07/144,887 →
Cyclosporin Peptolides Having an Alpha-Hydroxycarboxylic Acid at Position 8
Patent:
5,116,816 →
Application:
07/209,680 →
Monoclonal Antibodies to Cyclosporins
Patent:
5,169,773 →
Application:
07/265,374 →
2-Substituted-8ALPHA-Branched Chain Acylaminoergolines
Patent:
4,950,672 →
Application:
07/316,363 →
New Use of 5 HT3 Antagonists in Preventing or Reducing Dependency on Dependency-Inducing Agents
Patent:
5,039,680 →
Application:
07/467,598 →
Novel 8ALPHA-Acylaminoergolines
Patent:
5,077,298 →
Application:
07/547,899 →
Immunosuppressant Factor Protein Capable of Inhibiting T-Cell Mechanisms
Patent:
5,095,095 →
Application:
07/553,096 →
Nasal Pharmaceutical Compositions
Patent:
5,169,849 →
Application:
07/603,990 →
Use of 5 Ht-3 Antagonists in Preventing or Reducing Dependency on Dependency-Inducing Agents
Patent:
5,198,459 →
Application:
07/711,226 →
Use of 5HT-3 Antagonists in Preventing or Reducing Dependency on Dependency-Inducing Agents
Patent:
5,272,168 →
Application:
08/006,023 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Mar 2, 1980
From: BERNEY DANIEL
To: SANDOZ LTD. (ALSO KNOWN AS SANDOZ AG), A COMPANY OF SWITZERLAND
Reel/Frame 003834/0009 →
Assignment of Assignors Interest.
Oct 18, 1982
From: SANDOZ LTD.
To: FIDELITY UNION TRUST COMPANY,EXECUTIVE TRUSTEE UNDER SANDOZ TRUST OF MAY 4,1955
Reel/Frame 004055/0740 →
Assignment of Assignors Interest.
Sep 26, 1983
From: FIDELITY UNION BANK, FORMERLY K/A FIDELITY UNION TRUST COMPANY, A NJ CORP
To: SANDOZ INC., A CORP. OF DE.
Reel/Frame 004172/0924 →
Assignment of Assignors Interest.
Dec 19, 1983
From: CARDINAUX, FRANCOIS; HUGUENIN, RENE; PLESS, JANOS; SANDRIN, EDMOND
To: SANDOZ LTD., 4002 BASLE, SWITZERLAND, A COMPANY
Reel/Frame 004203/0108 →
Assignment of Assignors Interest.
May 29, 1984
From: NEUMANN, PETER
To: SANDOZ LTD. (A/K/A SANDOZ AG)
Reel/Frame 004264/0794 →
Assignment of Assignors Interest.
May 9, 1988
From: WENGER, ROLAND
To: SANDOZ LTD. (ALSO KNOWN AS SANDOZ AG)
Reel/Frame 004865/0222 →
Assignment of Assignors Interest.
Nov 13, 1989
From: BARNAVON, MARC; DUTRUEL, PHILIPPE; RAVAUX, RENE
To: SANDOZ LTD., 4002 BASLE, SWITZERLAND, A SWISS CO.
Reel/Frame 005271/0587 →
Assignment of Assignors Interest.
Jan 5, 1990
From: BUCHHEIT, KARL-HEINZ
To: SANDOZ LTD.
Reel/Frame 005206/0673 →
Assignment of Assignors Interest.
Dec 13, 1991
From: DREYFUSS, MICHAEL M.; SCHREIER, MAX H.; TSCHERTER, HANS
To: SANDOZ LTD., (ALSO KNOWN AS SANDOZ AG)
Reel/Frame 005945/0228 →
Assignment of Assignors Interest.
Sep 3, 1992
From: ROSENTHALER, JOACHIM; WENGER, ROLAND; BALL, PHILIPP E.; SCHREIER, MAX H.
To: SANDOZ LTD.
Reel/Frame 006258/0994 →
Assignment of Assignors Interest.
Sep 3, 1992
From: KIECHEL, JEAN-RENE; ACEZAT-MISOELTER, FRANCOIS; FLAS, DANIELLE
To: SANDZO LTD
Reel/Frame 006258/0996 →
Change of Name
Dec 19, 1997
From: SANDOZ PHARMACEUTICALS CORPORATION
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 008869/0445 →
Assignment of Assignor's Interest
Jul 19, 2000
From: NOVARTIS PHARMACEUTICALS CORPORATION
To: NOVARTIS AG
Reel/Frame 010984/0894 →
Assignment of Assignor's Interest
Mar 24, 2003
From: NOVARTIS AG
To: RELIANT PHARMACEUTICALS, LLC
Reel/Frame 013879/0330 →
Assignment of Assignor's Interest
Mar 27, 2003
From: NOVARTIS AG
To: XCEL PHARMACEUTICALS, INC.
Reel/Frame 013897/0624 →
Security Interest
Apr 2, 2003
From: XOEL PHARMACEUTICALS, INC.
To: REGIMENT CAPITAL III, L.P.
Reel/Frame 013897/0194 →
Security Agreement
Apr 30, 2003
From: RELIANT PHARMACEUTICALS, LLC
To: BAY CITY CAPITAL FUND
Reel/Frame 013998/0275 →
Release of Security Interest
Feb 9, 2004
From: BAY CITY CAPITAL FUND III, L.P., THE
To: RELIANT PHARMACEUTICALS, LLC
Reel/Frame 014964/0671 →
Security Agreement
Sep 8, 2004
From: RELIANT PHARMACEUTICALS, INC.
To: CREDIT SUISSE FIRST BOSTON
Reel/Frame 015116/0592 →
Security Agreement
Sep 27, 2004
From: RELIANT PHARMACEUTICALS, INC.
To: CREDIT SUISSE FIRST BOSTON
Reel/Frame 015810/0418 →
Release of Security Agreement
Mar 7, 2005
From: REGIMENT CAPITAL III, L.P.
To: XCEL PHARMACEUTICALS, INC.
Reel/Frame 015732/0626 →
Security Interest
Apr 18, 2005
From: RELIANT PHARMACEUTICALS, INC.
To: BANK OF NEW YORK, THE
Reel/Frame 016460/0713 →
Security Agreement
May 9, 2007
From: RELIANT PHARMACEUTICALS, INC.
To: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
Reel/Frame 019265/0086 →
Release of Security Interest
Jul 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
To: RELIANT PHARMACEUTICALS, INC.
Reel/Frame 024741/0060 →
Security Agreement
Oct 4, 2010
From: ATON PHARMA, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA; VALEANT PHARMACEUTICALS INTERNATIONAL; CORIA LABORATORIES, LTD.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 025084/0169 →